NCT07783412 clinical trial report covering Ruxolitinib Phosphate, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07780838 clinical trial report covering Gemcitabine Hydrochloride, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07783191 clinical trial report covering Dextrose, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07781150 clinical trial report covering Mazdutide, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07781657 clinical trial report covering RO-7568282, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07783100 clinical trial report covering Venetoclax, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07781891 clinical trial report covering LX-101(Lirum Therapeutics), Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07784374 clinical trial report covering GFS202A, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07784413 clinical trial report covering Serplulimab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

ChiCTR2600130836 clinical trial report covering Albumin-Bound Paclitaxel, Phase 2, endpoints, sponsor, geography, readout timing and development white spac

NCT07784556 clinical trial report covering Ketamine Hydrochloride, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07783802 clinical trial report covering Clazakizumab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.